Infectious diseases research;Investigación en enfermedades infecciosas

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue SUPPL. 15, 2008, Pages 40-50

  Carratalà, Jordi ^a   Alcamí, José ^b   Cordero, Elisa ^c   Miró, José M ^d   Ramos, José Manuel ^e  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

AIDS; Experimental models; Infectious diseases; Investigation; Research networks; Scientific production

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; EDUCATION PROGRAM; EUROPE; INFECTION; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL SPECIALIST; MICROBIOLOGY; PROFESSIONAL KNOWLEDGE; SPAIN; ANIMAL; ANIMAL MODEL; BIBLIOMETRICS; CLINICAL TRIAL; COOPERATION; EDUCATION; EUROPEAN UNION; HEALTH SERVICES RESEARCH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS DISEASE MEDICINE; JOURNAL IMPACT FACTOR; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PHYSIOLOGY; PRODUCTIVITY; PUBLICATION; RESEARCH; REVIEW; STATISTICS;

ACADEMIES AND INSTITUTES; ANIMALS; BIBLIOMETRICS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; EFFICIENCY; EUROPEAN UNION; HEALTH SERVICES RESEARCH; HIV; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE MEDICINE; JOURNAL IMPACT FACTOR; MODELS, ANIMAL; PERIODICALS AS TOPIC; RESEARCH; SPAIN;

EID: 65449175700     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(08)76599-6     Document Type: Article

References (37)

1. H. Varmus Retroviruses Science 240 1998 1427 1435
2. R.C. Gallo History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2 Oncogene 24 2005 5926 5930 (Pubitemid 43086110)
3. Centers for Disease Control and Prevention Pneumocystis pneumoniae-Los Angeles Morbid Mortal Wkly Rep 30 1981 250 252
4. F. Barré-Sinoussi, J.C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, J. Gruest, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science 220 1983 868 871
5. J. Silberner AIDS blood screen approved Sci News 127 1985 48
6. S. Wain-Hobson, P. Sonigo, O. Danos, S. Cole, and M. Alizon Nucleotide sequence of the AIDS virus, LAV Cell 40 1985 9 17 (Pubitemid 15169301)
7. R. Pomerantz, and D. Horn Twenty years of therapy for HIV-1 infection Nat Med 9 2003 867 873 (Pubitemid 36889928)
8. E.M. Connor, R.S. Sperling, R. Gelber, P. Kiselev, G. Scott, M.J. O'Sullivan, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group N Engl J Med 331 1994 1173 1180
9. J.W. Mellors, A. Muñoz, J.V. Giorgi, J.B. Margolick, C.J. Tassoni, and P. Gupta Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection Ann Intern Med 126 1997 946 954 (Pubitemid 27255797)
10. X. Wei, S.K. Ghosh, M.E. Taylor, V.A. Johnson, E.A. Emini, P. Deutsch, et al. Viral dynamics in human immunodeficiency virus type 1 infection Nature 373 1995 117 122
11. Y. Feng, C.C. Broder, P.E. Kennedy, and E.A. Berger HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor Science 272 1996 872 877 (Pubitemid 26154590)
12. T. Dragic, V. Litwin, G.P. Allaway, S.R. Martin, Y. Huang, and K.A. Nagashima HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CCCKR-5 Nature 381 1996 667 673 (Pubitemid 26197680)
13. A.M. Caro-Murillo, J. Castilla, S. Pérez-Hoyos, J.M. Miró, D. Podzamczer, and R. Rubio Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results Enferm Infecc Microbiol Clin 25 2007 23 31 (Pubitemid 46232687)
14. O. Zak M. Sande, editors. Handbook of animal models of infection 1999 Academic Press London
15. García de la María., F. Marco, J.M. Miro The Hospital Clinic Experimental Endocarditis Study Group Modelling systems in bacterial disease: What do they tell us? Eur Infect Dis 2 2008 2 5
16. J.L. Mainardi, L. Gutmann, J. Acar, and F. Goldstein Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis Antimicrob Agent Chemother 39 1995 1984 1987
17. J. Gavaldà, C. Torres, C. Tenorio, P. López, M. Zaragoza, and J.A. Capdevila Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides Antimicrob Agents Chemother 43 1999 639 646 (Pubitemid 29109532)
18. J. Gavaldá, O. Len, J.M. Miró, P. Muñoz, M. Montejo, A. Alarcón, et al. Treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone Ann Intern Med 146 2007 574 579
19. J. Gavaldá, P.L. Onrubia, M.T. Gómez, X. Gomis, J.L. Ramírez, and O. Len Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides J Antimicrob Chemother 52 2003 514 517 (Pubitemid 37120740)
20. L.M. Baddour, W.R. Wilson, A.S. Bayer, V.G. Fowler Jr, A.F. Bolger, M.E. Levison, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America Circulation 111 2005 e394 e434
21. J.M. Miró J.M. Gatell, editors. Modelos experimentales en patología infecciosa. Fundación Dr. Antonio Esteve 2000 Ediciones Doyma S.L.; España Barcelona
22. S. Edberg The measurement of antibiotics in human body fluids: techniques and signifigance V. Lorian, editor. Antibiotics in laboratory medicine 1996 William and Wilkins, Co. Baltimore
23. J. Gavalda, P.J. Cardona, B. Almirante, J.A. Capdevila, M. Laguarda, and L. Pou Treatment of experimental endocarditis due to Enterococcus faecalis using once daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum Antimicrob Agents Chemother 40 1996 173 178 (Pubitemid 26019692)
24. J.M. Miro, C. García de la Mària, Y. Armero, E. De Lazzari, D. Soy, and A. Moreno Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus Antimcrob Agents Chemother 51 2007 2373 2377 (Pubitemid 47047313)
25. F. Marco, C. García de la Mària, Y. Armero, E. Amat, D. Soy, and A. Moreno Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus Antimicrob Agents Chemother 52 2008 2538 2543 (Pubitemid 351915686)
26. J. Martinez-Lacasa, C. Cabellos, A. Martos, A. Fernández, F. Tubau, and P.F. Viladrich Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis J Antimicrob Chemother 49 2002 507 513 (Pubitemid 34223672)
27. M.J. Rodríguez-Hernández, J. Pachón, C. Pichardo, L. Cuberos, J. Ibáñez-Martínez, and A. García-Curiel Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia J Antimicrob Chemother 45 2000 493 501 (Pubitemid 30199143)
28. A. Domenech, S. Ribes, C. Cabellos, M.A. Domínguez, A. Montero, and J. Linares A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections Microb Drug Resist 10 2004 346 353 (Pubitemid 40096572)
29. J.A. Capdevila, J. Gavaldà, J. Fortea, P. López, M.T. Martin, and X. Gomis Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibioticlock technique Clin Microbiol Infect 7 2001 206 212 (Pubitemid 34966119)
30. P.J. Cardona, I. Amat, S. Gordillo, V. Arcos, E. Guirado, and J. Diaz Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis Vaccine 23 2005 1393 1398 (Pubitemid 40127332)
31. J. Gavaldà, M.T. Martín, P. López, X. Gomis, J.L. Ramírez, and D. Rodríguez Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis Antimicrob Agents Chemother 49 2005 3028 3030 (Pubitemid 40917634)
32. J. Joseph, N. Saubi, E. Pezzat, and J.M. Gatell Progress towards an HIV vaccine based on recombinant bacillus Calmette-Guérin: failures and challenges Expert Rev Vaccines 5 2006 827 838 (Pubitemid 46021059)
33. R.E. Gagnon, A.J. Macnab, and F.A. Gagnon A quantitative ranking of Canada's research output of original human studies for the decade 1989 to 1998 Can Med Ass J 162 2000 37 40
34. L. Heffer, C. Tempfer, and C. Kainz Geography of biomedical publications in the European Union, 1990-98 Lancet 353 1999 1856 (Pubitemid 29251029)
35. J.M. Ramos-Rincón, M.M. Masía, and F. Gutiérrez Producción científica en España en enfermedades infecciosas (1991-2001): posición en el contexto de la Unión Europea Enferm Infecc Microbiol Clin 22 2004 22 28 (Pubitemid 38374123)
36. Institute for Scientific Information Web of Knowledge. Disponible en: www.isinet.com
37. Word Development Indicators 2006. Disponible en: http://web.worldbank. org/WBSITE/EXTERNAL/DATASTATISTICS/0,,contentMDK:20899413∼pa gePK:64133150∼piPK:64133175∼theSitePK:239419,00.htmls